— The Authors describe the favourable results obtained in 3 patients with Idiopathic Retroperitoneal Fibrosis (IRF) using a therapeutic protocol based on the association of prednisolone and cyclophosphamide. In 2 patients this therapy obtained a partial radiologic and total clinical remission; in the third case it guaranteed a stabilization of the results obtained by previous surgery. Given the absence of significant side effects, the protocol may be taken into consideration for practically all patients with TRF.
KayR.G.: Retroperitoneal vasculitis with perivascular fibrosis. Brit. J. Urol., 35: 284–292, 1963.
2.
WatersV.V.: Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report. J. Urol., 141: 936–937, 1989.
3.
ConnollyJ., EisnerD., GoldmanS., StutzmanR., SteinerM.: Benign retroperitoneal fibrosis and renal cell carcinoma. J. Urol., 149: 1535–1537, 1993.
4.
MitchinsonM.J., WithycombeJ.F.R., ArdenJones R.: The response of idiopathic retroperitoneal fibrosis to corticosteroids. Brit. J. Urol., 43: 444–449, 1971.
5.
McDougalW.S., MacDonellR.C.: Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J. Urol., 145: 112–114, 1991.
6.
ParumsD.V., ChoudhuryR.P., ShieldS.A., DaviesA.H.: Characterisation of inflammatory cells associated with “idiopathic retroperitoneal fibrosis”. Brit. J. Urol., 67: 564–568, 1991.
